Schedule 13G ownership disclosure
Protalix BioTherapeutics Inc
Security class unavailable · CUSIP: 74365A309
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-20-003584
- Form type
- SC 13G
- Filer
- Protalix BioTherapeutics, Inc.
- CIK
- CIK 1006281
- Filed
- Feb 13, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership